Feasibility of state of the art PET/CT systems performance harmonisation

被引:125
作者
Kaalep, Andres [1 ]
Sera, Terez [2 ,3 ]
Rijnsdorp, Sjoerd [4 ]
Yaqub, Maqsood [5 ]
Talsma, Anne [6 ]
Lodge, Martin A. [7 ]
Boellaard, Ronald [3 ,5 ,8 ]
机构
[1] North Estonia Med Ctr Fdn, Dept Med Technol, J Sutiste Str 19, EE-13419 Tallinn, Estonia
[2] Univ Szeged, Dept Nucl Med, Szeged, Hungary
[3] EANM Res Ltd EARL, Vienna, Austria
[4] Catharina Hosp, Dept Med Phys, Eindhoven, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[6] Martini Hosp, Dept Radiol, Groningen, Netherlands
[7] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Hanzepl 1, Groningen, Netherlands
关键词
Performance; Harmonisation; PET/CT; Quantification; EARL accreditation; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; STANDARDIZED UPTAKE VALUE; F-18-FDG PET; FDG-PET; MULTICENTER TRIALS; RESPONSE ASSESSMENT; CLINICAL-TRIALS; ROI DEFINITION; TUMOR RESPONSE;
D O I
10.1007/s00259-018-3977-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The objective of this study was to explore the feasibility of harmonising performance for PET/CT systems equipped with time-of-flight (ToF) and resolution modelling/point spread function (PSF) technologies. A second aim was producing a working prototype of new harmonising criteria with higher contrast recoveries than current EARL standards using various SUV metrics. Methods Four PET/CT systems with both ToF and PSF capabilities from three major vendors were used to acquire and reconstruct images of the NEMA NU2-2007 body phantom filled conforming EANM EARL guidelines. A total of 15 reconstruction parameter sets of varying pixel size, post filtering and reconstruction type, with three different acquisition durations were used to compare the quantitative performance of the systems. A target range for recovery curves was established such that it would accommodate the highest matching recoveries from all investigated systems. These updated criteria were validated on 18 additional scanners from 16 sites in order to demonstrate the scanners' ability to meet the new target range. Results Each of the four systems was found to be capable of producing harmonising reconstructions with similar recovery curves. The five reconstruction parameter sets producing harmonising results significantly increased SUVmean (25%) and SUVmax (26%) contrast recoveries compared with current EARL specifications. Additional prospective validation performed on 18 scanners from 16 EARL accredited sites demonstrated the feasibility of updated harmonising specifications. SUVpeak was found to significantly reduce the variability in quantitative results while producing lower recoveries in smaller (<= 17 mm diameter) sphere sizes. Conclusions Harmonising PET/CT systems with ToF and PSF technologies from different vendors was found to be feasible. The harmonisation of such systems would require an update to the current multicentre accreditation program EARL in order to accommodate higher recoveries. SUVpeak should be further investigated as a noise resistant alternative quantitative metric to SUVmax.
引用
收藏
页码:1344 / 1361
页数:18
相关论文
共 56 条
[1]   Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC) [J].
Agarwal, Mohit ;
Brahmanday, Govinda ;
Bajaj, Sunil K. ;
Ravikrishnan, K. P. ;
Wong, Ching-Yee Oliver .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (04) :691-698
[2]   Monitoring response to treatment in patients utilizing PET [J].
Avril, NE ;
Weber, WA .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2005, 43 (01) :189-+
[3]   The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis [J].
Bastiaannet, E ;
Groen, H ;
Jager, PL ;
Cobben, DCP ;
van der Graaf, WTA ;
Vaalburg, W ;
Hoekstra, HJ .
CANCER TREATMENT REVIEWS, 2004, 30 (01) :83-101
[4]  
Boel R, 2013, INT CONF INSTRUM, P1, DOI 10.1109/ICA.2013.6734036
[5]   FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 [J].
Boellaard, Ronald ;
Delgado-Bolton, Roberto ;
Oyen, Wim J. G. ;
Giammarile, Francesco ;
Tatsch, Klaus ;
Eschner, Wolfgang ;
Verzijlbergen, Fred J. ;
Barrington, Sally F. ;
Pike, Lucy C. ;
Weber, Wolfgang A. ;
Stroobants, Sigrid ;
Delbeke, Dominique ;
Donohoe, Kevin J. ;
Holbrook, Scott ;
Graham, Michael M. ;
Testanera, Giorgio ;
Hoekstra, Otto S. ;
Zijlstra, Josee ;
Visser, Eric ;
Hoekstra, Corneline J. ;
Pruim, Jan ;
Willemsen, Antoon ;
Arends, Bertjan ;
Kotzerke, Joerg ;
Bockisch, Andreas ;
Beyer, Thomas ;
Chiti, Arturo ;
Krause, Bernd J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :328-354
[6]   Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments [J].
Boellaard, Ronald .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 :93S-100S
[7]   Standards for PET Image Acquisition and Quantitative Data Analysis [J].
Boellaard, Ronald .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 :11S-20S
[8]   Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer [J].
Borst, GR ;
Belderbos, JSA ;
Boellaard, R ;
Comans, EFI ;
De Jaeger, K ;
Lammertsma, AA ;
Lebesque, JV .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) :1533-1541
[9]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[10]   Molecular imaging in the development of cancer therapeutics [J].
Czernin, J ;
Weber, WA ;
Herschman, HR .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :99-118